Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD).
Zhang T, Ambrodji A, Huang H, Bouchonville KJ, Etheridge AS, Schmidt RE, Bembenek BM, Temesgen ZB, Wang Z, Innocenti F, Stroka D, Diasio RB, Largiadèr CR, Offer SM. Zhang T, et al. Among authors: innocenti f. bioRxiv [Preprint]. 2024 Mar 16:2023.11.01.565230. doi: 10.1101/2023.11.01.565230. bioRxiv. 2024. Update in: Elife. 2024 Apr 30;13:RP94075. doi: 10.7554/eLife.94075. PMID: 37961517 Free PMC article. Updated. Preprint.
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
Nicoletti P, Dellinger A, Li YJ, Barnhart HX, Chalasani N, Fontana RJ, Odin JA, Serrano J, Stolz A, Etheridge AS, Innocenti F, Govaere O, Grove JI, Stephens C, Aithal GP, Andrade RJ, Bjornsson ES, Daly AK, Lucena MI, Watkins PB; Drug-Induced Liver Injury Network (DILIN); International Drug-Induced Liver Injury Consortium (iDILIC); Prospective European Drug-Induced Liver Injury (Pro-Euro DILI) Investigators. Nicoletti P, et al. Among authors: innocenti f. Gastroenterology. 2023 Mar;164(3):454-466. doi: 10.1053/j.gastro.2022.11.036. Epub 2022 Dec 7. Gastroenterology. 2023. PMID: 36496055 Free PMC article.
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Quintanilha JCF, Sibley AB, Liu Y, Niedzwiecki D, Halabi S, Rogers L, O'Neil B, Kindler H, Kelly W, Venook A, McLeod HL, Ratain MJ, Nixon AB, Innocenti F, Owzar K. Quintanilha JCF, et al. Among authors: innocenti f. medRxiv [Preprint]. 2023 Dec 4:2023.12.04.23298815. doi: 10.1101/2023.12.04.23298815. medRxiv. 2023. Update in: BMC Genomics. 2024 May 14;25(1):473. doi: 10.1186/s12864-024-10354-7. PMID: 38106038 Free PMC article. Updated. Preprint.
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Quintanilha JCF, Sibley AB, Liu Y, Niedzwiecki D, Halabi S, Rogers L, O'Neil B, Kindler H, Kelly W, Venook A, McLeod HL, Ratain MJ, Nixon AB, Innocenti F, Owzar K. Quintanilha JCF, et al. Among authors: innocenti f. BMC Genomics. 2024 May 14;25(1):473. doi: 10.1186/s12864-024-10354-7. BMC Genomics. 2024. PMID: 38745123 Free PMC article.
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance).
Nakasone ES, Zemla TJ, Yu M, Lin SY, Ou FS, Carter K, Innocenti F, Saltz L, Grady WM, Cohen SA. Nakasone ES, et al. Among authors: innocenti f. Epigenetics. 2024 Dec;19(1):2349980. doi: 10.1080/15592294.2024.2349980. Epub 2024 May 8. Epigenetics. 2024. PMID: 38716804 Free PMC article. Clinical Trial.
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
Arai H, Yang Y, Baca Y, Millstein J, Denda T, Ou FS, Innocenti F, Takeda H, Kubota Y, Doi A, Horie Y, Umemoto K, Izawa N, Wang J, Battaglin F, Jayachandran P, Algaze S, Soni S, Zhang W, Goldberg RM, Hall MJ, Scott AJ, Hwang JJ, Lou E, Weinberg BA, Marshall J, Goel S, Xiu J, Michael Korn W, Venook AP, Sunakawa Y, Lenz HJ. Arai H, et al. Among authors: innocenti f. Eur J Cancer. 2024 Apr;201:113914. doi: 10.1016/j.ejca.2024.113914. Epub 2024 Feb 10. Eur J Cancer. 2024. PMID: 38359495
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.
Sanoff HK, Deal AM, Patel J, Sorah JD, Gaddy J, O'Neil B, Turk A, Irvin W, Boles J, Lee MS, McRee A, Wardell AC, Weck KE, Basch E, Wood WA, Innocenti F. Sanoff HK, et al. Among authors: innocenti f. Oncologist. 2024 Sep 6;29(9):786-793. doi: 10.1093/oncolo/oyae122. Oncologist. 2024. PMID: 38837045 Free PMC article. Clinical Trial.
426 results